Innovative Trial Designs for Improving TB Drug Development.

Innovative trial designs for improving TB drug development.

Filed under: Drug and Alcohol Rehabilitation

J Infect Dis. 2012 Nov 21;
Dodd LE, Proschan MA

HubMed – drug

 

MPs are to investigate need for drug companies to share clinical trial data.

Filed under: Drug and Alcohol Rehabilitation

BMJ. 2012; 345: e7980
Iacobucci G

HubMed – drug

 

Modulation of Vigilance in the Primary Hypersomnias by Endogenous Enhancement of GABAA Receptors.

Filed under: Drug and Alcohol Rehabilitation

Sci Transl Med. 2012 Nov 21; 4(161): 161ra151
Rye DB, Bliwise DL, Parker K, Trotti LM, Saini P, Fairley J, Freeman A, Garcia PS, Owens MJ, Ritchie JC, Jenkins A

The biology underlying excessive daytime sleepiness (hypersomnolence) is incompletely understood. After excluding known causes of sleepiness in 32 hypersomnolent patients, we showed that, in the presence of 10 ?M ?-aminobutyric acid (GABA), cerebrospinal fluid (CSF) from these subjects stimulated GABA(A) receptor function in vitro by 84.0 ± 40.7% (SD) relative to the 35.8 ± 7.5% (SD) stimulation obtained with CSF from control subjects (Student’s t test, t = 6.47, P < 0.0001); CSF alone had no effect on GABA(A) signaling. The bioactive CSF component had a mass of 500 to 3000 daltons and was neutralized by trypsin. Enhancement was greater for ?2 subunit- versus ?1 subunit-containing GABA(A) receptors and negligible for ?4 subunit-containing ones. CSF samples from hypersomnolent patients also modestly enhanced benzodiazepine (BZD)-insensitive GABA(A) receptors and did not competitively displace BZDs from human brain tissue. Flumazenil-a drug that is generally believed to antagonize the sedative-hypnotic actions of BZDs only at the classical BZD-binding domain in GABA(A) receptors and to lack intrinsic activity-nevertheless reversed enhancement of GABA(A) signaling by hypersomnolent CSF in vitro. Furthermore, flumazenil normalized vigilance in seven hypersomnolent patients. We conclude that a naturally occurring substance in CSF augments inhibitory GABA signaling, thus revealing a new pathophysiology associated with excessive daytime sleepiness. HubMed – drug

 


 

A-1 Solutions Counseling Service – www.dexknows.com Don’t let drugs and alcohol dictate your life. Take control with A-One Solutions Counseling Service. We’re a drug and alcohol rehabilitation center, and we want to get you on the road to recovery. We offer evaluations, treatment programs, DUI programs, and much more. It’s our goal to free you from addiction.

 

More Drug And Alcohol Rehabilitation Information…